Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect
Kerri A Schoedel,1 Sarah A Morrow,2 Edward M Sellers3,4 1Altreos Research Partners, Inc., Toronto, 2Western University, London, 3DL Global Partners, Inc., Toronto, 4University of Toronto, Toronto, Ontario, Canada Abstract: Pseudobulbar affect (PBA) is a common manifestation of brain pathology ass...
Guardado en:
Autores principales: | Schoedel KA, Morrow SA, Sellers EM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/930cbf7bce314eed9687b3801c1446fe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnosing pseudobulbar affect in traumatic brain injury
por: Engelman W, et al.
Publicado: (2014) -
Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody–associated disease: a systematic review and meta-analysis
por: Qi-Lun Lai, et al.
Publicado: (2021) -
Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang XF, et al.
Publicado: (2015) -
Correlation between cognitive impairment during the acute phase of first cerebral infarction and development of long-term pseudobulbar affect
por: Wang Y, et al.
Publicado: (2018) -
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
por: Howard E. Gendelman, et al.
Publicado: (2017)